Elevance Health, Inc.
ELV
$528.89
$1.930.37%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 36.16B | 35.67B | 35.75B | 37.01B | 36.26B |
| Total Other Revenue | 6.42B | 6.98B | 7.10B | 6.67B | 5.92B |
| Total Revenue | 42.58B | 42.65B | 42.85B | 43.67B | 42.17B |
| Cost of Revenue | 30.55B | 31.33B | 30.61B | 31.60B | 30.79B |
| Gross Profit | 12.03B | 11.31B | 12.24B | 12.07B | 11.39B |
| SG&A Expenses | 8.71B | 8.69B | 9.39B | 9.15B | 8.28B |
| Depreciation & Amortization | 116.00M | 217.00M | 212.00M | 221.00M | 235.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.37B | 40.24B | 40.21B | 40.97B | 39.30B |
| Operating Income | 3.20B | 2.40B | 2.64B | 2.70B | 2.87B |
| Income Before Tax | 2.94B | 1.00B | 1.65B | 2.44B | 2.62B |
| Income Tax Expenses | 690.00M | 170.00M | 354.00M | 585.00M | 615.00M |
| Earnings from Continuing Operations | 2.25B | 831.00M | 1.30B | 1.86B | 2.00B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.00M | 25.00M | -11.00M | -3.00M | -15.00M |
| Net Income | 2.25B | 856.00M | 1.29B | 1.85B | 1.99B |
| EBIT | 3.20B | 2.40B | 2.64B | 2.70B | 2.87B |
| EBITDA | 3.54B | 2.83B | 3.07B | 3.14B | 3.33B |
| EPS Basic | 9.65 | 3.63 | 5.48 | 7.83 | 8.37 |
| Normalized Basic EPS | 7.88 | 5.79 | 6.29 | 6.44 | 6.83 |
| EPS Diluted | 9.59 | 3.63 | 5.45 | 7.79 | 8.30 |
| Normalized Diluted EPS | 7.83 | 5.79 | 6.25 | 6.40 | 6.77 |
| Average Basic Shares Outstanding | 232.70M | 235.80M | 235.30M | 236.60M | 237.50M |
| Average Diluted Shares Outstanding | 234.20M | 235.80M | 236.50M | 237.80M | 239.70M |
| Dividend Per Share | 1.63 | 1.48 | 1.48 | 1.48 | 1.48 |
| Payout Ratio | 16.87% | 40.42% | 27.00% | 18.89% | 17.65% |
